药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Dioxaphetyl butyrate
Sulfate ion
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sulfate ion.
Dioxaphetyl butyrate
Dehydrocholic acid
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Dehydrocholic acid.
Dioxaphetyl butyrate
Frangula purshiana bark
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Frangula purshiana bark.
Dioxaphetyl butyrate
Alloin
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Alloin.
Dioxaphetyl butyrate
Konjac mannan
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Konjac mannan.
Dioxaphetyl butyrate
Calcium polycarbophil
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Calcium polycarbophil.
Dioxaphetyl butyrate
Oxyphenisatin acetate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Oxyphenisatin acetate.
Dioxaphetyl butyrate
Plantago ovata seed
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Plantago ovata seed.
Dioxaphetyl butyrate
Sodium cation
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium cation.
Dioxaphetyl butyrate
Magnesium
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium.
Dioxaphetyl butyrate
Sodium phosphate, dibasic, unspecified form
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium phosphate, dibasic, unspecified form.
Dioxaphetyl butyrate
Sodium phosphate, monobasic, unspecified form
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium phosphate, monobasic, unspecified form.
Dioxaphetyl butyrate
Sodium phosphate, dibasic
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium phosphate, dibasic.
Dioxaphetyl butyrate
Potassium sulfate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Potassium sulfate.
Dioxaphetyl butyrate
Sodium ascorbate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium ascorbate.
Dioxaphetyl butyrate
Deacetylbisacodyl
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Deacetylbisacodyl.
Dioxaphetyl butyrate
Magnesium acetate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium acetate.
Dioxaphetyl butyrate
Sodium tartrate
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Sodium tartrate.
Dioxaphetyl butyrate
Pentaerithrityl
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Pentaerithrityl.
Dioxaphetyl butyrate
Magnesium peroxide
The risk or severity of adverse effects can be increased when Ertugliflozin is combined with Magnesium peroxide.